7 medtech stories we missed this week: June 22, 2018
[Image from unsplash.com]From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. India approves Accuray’s Radixact X9 radiation therapy device
Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in India for its Radixact X9 System. The approval allows the company to sell the TomoTherapy platform while allowing hospitals throughout India to import the system. The Radixact and TomoTherapy Systems are radiation therap...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Regulatory/Compliance Ultrasound Accuray Inc. Arcuro Medical BTG Masimo MedTech NuSight P Source Type: news
Johnson & Johnson launches new self-shortening Dynacord suture
[Image courtesy of Johnson & Johnson]Johnson & Johnson through its DePuy Synthes franchise has announced the U.S. launch of its Dynacord suture for soft tissue repair in areas such as the rotator cuff in the shoulder.
The Dynacord suture, available on Healix Advance anchors, is part of the DePuy Synthes Mitek Sports Medicine portfolio. J&J launched Dynacord today at the San Diego Shoulder Institute’s 35th Annual Course.
About a fifth of arthroscopic rotator cuff surgeries fail because of a loss of suture tension, which causes gaps to form in the tissue or between the tissue and bone, according to J&...
Source: Mass Device - June 20, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News News Well Orthopedics Surgical depuysynthes johnsonandjohnson Source Type: news
Apollo Endosurgery prices $21m offering
Apollo Endosurgery today priced a stock offering worth nearly $21 million for its line of bariatric and gastrointestinal devices.
Austin, Texas-based Apollo said it plans to float roughly 3.75 million shares at $5.50 apiece, for gross proceeds of $20.6 million.
The offering also includes a 45-day option for underwriter Craig-Hallum Capital of another 562,055 shares, which would add $3.1 million if exercised in full, the company said.
In March, the FDA approved Apollo’s move to terminate a post-approval study of its Lap-Band weight loss device, based on availability of long-term safety and effectiveness data on the devic...
Source: Mass Device - June 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Funding Roundup Wall Street Beat Weight loss Apollo Endosurgery Bariatrics Source Type: news
Bronchoscopes still dirty after cleaning, study says
Photo by Michaela33 courtesy of Flikr
A new study has found that currently acceptable methods of reprocessing reusable bronchoscopes left most devices contaminated and damaged.
“The results are worrisome as patients undergoing bronchoscopy are commonly at high risk for infection due to transplant status, critical illness, or immune-suppression due to malignancy or chronic disease,” said the study, funded by 3M and supported by sterilization product maker Healthmark Industries. It was presented last week at the Association for Professionals in Infection Control’s annual conference APIC 2018, will be publi...
Source: Mass Device - June 19, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Diagnostics Endoscopic / Arthroscopic Regulatory/Compliance Sterilization / Calibration 3m Healthmark superbugs Source Type: news
Researchers Assert Arthroscopic Partial Meniscectomy No Better Than Placebo Surgery
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - June 15, 2018 Category: Orthopaedics Tags: CME Article Source Type: news
Can You Smell a Bidding War Brewing Over Boston Scientific?
Monday's headlines that Stryker may be making a play for Boston Scientific prompted industry analysts to play the "what if" game, dissecting potential benefits of such a marriage, how a deal of that size might impact the broader medical device industry, and the potential of other bidders to emerge.
Just to be clear though, we still do not know at this point if Stryker really has approached Boston Scientific about a potential takeover, or if Boston Scientific is even receptive to the idea. Both companies declined to comment on the speculation Monday, citing their respective company policies.
Canaccord Genuity's Jason Mills ...
Source: MDDI - June 13, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news
Medical News Today: What is knee arthroscopy?
Knee arthroscopy is a surgical procedure. A surgeon inserts a tool called an arthroscope through a small incision. Using this scope and the camera attached, they can confirm diagnoses and often correct any issues affecting the joint. In this article, learn how to prepare and what to expect from knee arthroscopy. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 11, 2018 Category: Consumer Health News Tags: Surgery Source Type: news
7 medtech stories we missed this week: June 8, 2018
[Image from unsplash.com]From Royal Philips receiving FDA clearance to NeuroPace launching its epilepsy treatment device, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. FDA clears Philips’s Ingenia Elition 3.0T MR scanner
Royal Philips announced in a June 5 press release that it has received FDA 510(k) clearance for its Ingenia Elition 3.0T MR solution and its two clinical applications Philips Compressed Sense and 3D APT. The products help clinicians perform exams up to 50% faster while increasing diagnostic confidence and improving patient experience.
2. Pentax to di...
Source: Mass Device - June 8, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Implants Neurological Neuromodulation/Neurostimulation Patient Monitoring Regulatory/Compliance branchpointtechnologies Cook Medica Source Type: news
Arthroscopic repair of bony Bankart lesions in collision athletes - Shah N, Nadiri MN, Torrance E, Funk L.
BACKGROUND: The present study aimed to report the outcomes of acute and subacute arthroscopic bony Bankart repairs in collision athletes. METHODS: We reviewed 22 consecutive rugby players with traumatic anterior glenohumeral instability who underwe... (Source: SafetyLit)
Source: SafetyLit - May 30, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Lumendi wins FDA nod for DiLumen IS endoscopic scissors
Lumendi said today it won FDA 510(k) clearance for its DiLumen IS endolumenal interventional scissors, now indicated for cutting, dissecting and cauterizing tissue within the digestive tract during endoscopic procedures.
The Westport, Conn.-based company touted the sterile, single-use disposable, monopolar electrosurgical device as the fourth it’s developed, and said that it and its recently cleared DiLumen CT are intended to help improve access and therapy in the colon and reduce the need for surgical interventions.
The recently cleared C2 is a second-gen Endolumenal interventional platform designed to ensure com...
Source: Mass Device - May 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Lumendi Source Type: news
Return-to-play and performance outcomes of professional athletes in North America after hip arthroscopy from 1999 to 2016 - Schallmo MS, Fitzpatrick TH, Yancey HB, Marquez-Lara A, Luo TD, Stubbs AJ.
BACKGROUND: The effect of hip arthroscopy on athletic performance compared with preinjury levels for professional athletes in different sports remains unknown. In addition, while return rates have been reported for professional baseball, football, and hock... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Auris Health, Ethicon ’ s NeuWave ink robot-assisted bronchoscope ablation dev deal
Auris Health, previously known as Auris Surgical Robotics, said today it inked a cooperative development and commercialization deal with Johnson & Johnson (NYSE:JNJ) division Ethicon’s NeuWave Medical subsidiary looking to develop systems for the robotically-assisted bronchoscopic ablation of lung lesions.
Through the agreement, both companies will help develop an integrated system for robotic control, navigation and application of bronchoscope-delivered microwave ablation. The bronchoscope in development will be equipped with a small camera and accessory channel to allow tools to enter the lungs through the mou...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Endoscopic / Arthroscopic Respiratory Robotics aurishealth Ethicon johnsonandjohnson NeuWave Medical Inc. Source Type: news
Cook Medical wins FDA de novo nod for Hemospray
Cook Medical said yesterday it won FDA de novo clearance for its Hemospray endoscopic hemostat designed for treating bleeding in the gastrointestinal tract.
The Hemospray product won indications from the FDA for treating non-variceal GI bleeds, the Bloomington, Ind.-based company said. Hemospray is a single-use device designed to deliver an aerosolized spray of a mineral blend to a bleeding site during endoscopic procedures, and can cover large areas including ulcers and tumors, according to an FDA release.
“We are extremely pleased to receive this approval to market from FDA. We have worked diligently to bring a di...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Cook Medical Source Type: news
Merit Medical gets in on NinePoint ’ s NvisionVLE OCT
NinePoint Medical said today that it inked a long-term deal with Merit Medical (NSDQ:MMSI) division Endotek to distribute its NvisionVLE optical coherence tomography device that includes strategic investment of an unspecified amount.
“NinePoint Medical is committed to providing GI physicians an elegant and cost-effective OCT imaging solution to enable early and accurate diagnosis,” president & CEO Christopher von Jako said in prepared remarks. “Merit Medical Endotek is the ideal partner as they have the reputation, clinical experience, and complementary product portfolio to grow this business.”...
Source: Mass Device - May 1, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Imaging Wall Street Beat Merit Medical Systems Inc. NinePoint Medical Inc. Source Type: news
Mayo Clinic opens new simulation skills lab to help staff learn, perfect clinical procedures
JACKSONVILLE, Fla.? A new procedural skills lab in the Mayo Clinic J. Wayne and Delores Barr Weaver Simulation Center at?Mayo Clinic in Florida will help staff learn and perfect various clinical procedures, including joint arthroscopy, spinal taps and kidney removal. In addition, participants in the lab will experiment, learn and refine new procedures on tissue [...] (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - May 1, 2018 Category: Hospital Management Source Type: news
